Instil Bio, Inc.
TILNASDAQHealthcare● Active
$8.08
+$0.01(+0.12%)
Market Cap$54798366
P/E Ratio—
52W High$42.79
52W Low$5.67
Instil Bio, Inc. (TIL) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · TIL · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Cost of Revenue | $0.00B | $0.00B | $0.00B | $0.01B | $0.00B |
| Gross Profit | ($0.00B) | $0.00B | $0.00B | ($0.01B) | $0.00B |
| Gross Margin %(computed) | — | — | — | — | — |
| Operating Expenses | |||||
| R&D Expenses | $0.01B | $0.01B | $0.04B | $0.14B | $0.11B |
| G&A Expenses | $0.03B | $0.04B | $0.05B | $0.06B | $0.05B |
| Total Operating Expenses | $0.05B | $0.07B | $0.16B | $0.20B | $0.16B |
| Operating Income | ($0.05B) | ($0.07B) | ($0.16B) | ($0.21B) | ($0.16B) |
| Operating Margin %(computed) | — | — | — | — | — |
| Interest Income | $0.00B | $0.01B | $0.01B | $0.00B | $0.00B |
| Interest Expense | $0.01B | $0.01B | $0.01B | $0.00B | $0.00B |
| Income Before Tax | ($0.07B) | ($0.07B) | ($0.16B) | ($0.23B) | ($0.16B) |
| Income Tax Expense | $0.00B | $0.00B | $0.00B | ($0.00B) | $0.00B |
| Net Income | ($0.07B) | ($0.07B) | ($0.16B) | ($0.22B) | ($0.16B) |
| Net Margin %(computed) | — | — | — | — | — |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-10.70 | $-11.39 | $-24.00 | $-34.46 | $-29.60 |
| Wtd Avg Shares | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B |
| EBITDA | ($0.05B) | ($0.06B) | ($0.15B) | ($0.22B) | ($0.15B) |
| EBITDA Margin %(computed) | — | — | — | — | — |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · USD · B
Explore more Instil Bio, Inc. data
About Instil Bio, Inc. (TIL) Income Statement
Instil Bio, Inc. (TIL) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, TIL reported revenue of $0.00B, gross profit of ($0.00B) (gross margin —), and net income of ($0.07B) — a net profit margin of —.
Frequently asked questions
TIL · 4 questionsInstil Bio, Inc. (TIL) reported revenue of $0.00B for 2025, down —% year-over-year.
TIL revenueTIL salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09